UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059310 |
|---|---|
| Receipt number | R000067825 |
| Scientific Title | East Asian collaborative Study to Establish the standardized care for the Dying process |
| Date of disclosure of the study information | 2026/01/01 |
| Last modified on | 2026/01/01 16:39:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Multicenter International Collaborative Study on Establishing Standardized End-of-Life Care Methods for Cancer Patients
Acronym
EASED2
Scientific Title
East Asian collaborative Study to Establish the standardized care for the Dying process
Scientific Title:Acronym
EASED2
Region
| Japan | Asia(except Japan) |
Condition
Condition
Cancer
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To identify the most effective end-of-life care methods for managing symptoms in patients with cancer
Basic objectives2
Others
Basic objectives -Others
To explore the differences of end-of-life care methods for managing symptoms in patients with cancer among Japan, South Korea, and Taiwan
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Accuracy of clinician's prediction of functional survival
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Patients aged 18 years or older
(2) Cancer patients with locally advanced or metastatic disease diagnosed by histological, cytological, or clinical means
(3) Patients admitted to a palliative care unit or palliative care bed
Key exclusion criteria
(1) Patients scheduled for transfer or discharge
(2) Patients who have expressed refusal to participate in this study to the patient or family
(3) Patients deemed unsuitable for participation in this study by the attending physician
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | Yusuke |
| Middle name | |
| Last name | Hiratsuka |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Palliative Medicine
Zip code
980-8575
Address
2-1 Seiryo-cho, Aoba Ward, Sendai City, Miyagi Prefecture
TEL
022-717-7366
yusuke.hiratsuka.e6@tohoku.ac.jp
Public contact
Name of contact person
| 1st name | Yusuke |
| Middle name | |
| Last name | Hiratsuka |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Palliative Medicine
Zip code
980-8575
Address
2-1 Seiryo-cho, Aoba Ward, Sendai City, Miyagi Prefecture
TEL
022-717-7366
Homepage URL
yusuke.hiratsuka.e6@tohoku.ac.jp
Sponsor or person
Institute
Tohoku University
Institute
Department
Personal name
Funding Source
Organization
Japanese Society for Palliative Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee Tohoku University Graduate School of Medicine
Address
2-1 Seiryo-cho, Aoba Ward, Sendai City, Miyagi Prefecture
Tel
022-728-4105
ec-med@grp.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 01 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 10 | Month | 07 | Day |
Date of IRB
| 2025 | Year | 11 | Month | 20 | Day |
Anticipated trial start date
| 2026 | Year | 01 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Open public recruiting
Management information
Registered date
| 2025 | Year | 10 | Month | 06 | Day |
Last modified on
| 2026 | Year | 01 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067825
